Skip to main content
Premium Trial:

Request an Annual Quote

New York Approves AssureRx's Lab

The story has been corrected to say that certification from New York is for AssureRx's laboratory not its GeneSightRx test.

NEW YORK (GenomeWeb News) – The New York State Department of Health has certified AssureRx's laboratory, allowing residents in the state access to the company's pharmacogenomic test, GeneSightRx.

As a result of the approval, the Mason, Ohio-based company's laboratory is certified to analyze DNA samples for pharmacogenomic testing in all 50 states.

GeneSightRx is for helping determine which psychiatric drugs may be most effective for a patient. The test was launched in late 2009 and combines pharmacogenomic data from scientific and clinical publications, information from drug labels, and the patient's genetic profile. A cheek swab is taken from a patient then analyzed at AssureRx's CLIA-certified laboratory.

As GenomeWeb Daily News' sister publication Pharmacogenomics Reporter said last week, AssureRx has made improvements to the test by adding new therapies on the test panel and launching a mobile device application to give doctors greater flexibility in ordering and viewing test results.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.